Learn how long the FDA takes to approve generic drugs in 2026, what affects approval times, and how faster reviews are lowering drug costs. Real data, real timelines.
Read more
Recent advances in bioequivalence testing are transforming how generic drugs are approved. AI tools like BEAM, virtual bioequivalence models, and advanced imaging are replacing outdated clinical trials, cutting costs and timelines while improving accuracy.
Read more
Learn which antihypertensive combination generics are available, how much they cost, and how to get them covered by insurance. Real-world pricing, dosing limits, and global access insights.
Read more
Sleep Restriction Therapy resets chronic insomnia by limiting time in bed to match actual sleep, building sleep pressure for deeper, more efficient rest-without pills. Proven, durable, and backed by science.
Read more
Vaccinations are safe for people on blood thinners when proper technique is used. Learn how to avoid bruising and bleeding with small needles and 10 minutes of firm pressure after the shot.
Read more
Corticosteroid-induced hyperglycemia affects up to half of patients on high-dose steroids. Learn how steroids spike blood sugar, who's at risk, how to monitor correctly, and why insulin is often the only effective treatment.
Read more
Certain drug combinations can cause fatal reactions-but many pharmacists miss them due to alert fatigue. Learn the top 5 dangerous interactions you must ask about, who’s most at risk, and how to protect yourself.
Read more
Insurance formularies control which drugs you can get and how much you pay. Learn how tiers, substitution rules, and prior authorization impact your medication access-and what you can do to protect yourself.
Read more
As of 2025, over 270 medications are in short supply in the U.S., including critical drugs like cisplatin, IV fluids, and ADHD treatments. Learn which drugs are hardest to find, why shortages keep happening, and how patients and providers are coping.
Read more
Medical societies have conflicting views on generic drug substitution. While most support generics for cost savings, neurologists and others warn against swapping NTI drugs like antiepileptics due to safety risks. Here’s what providers really think.
Read more